Polar Capital Holdings’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $109M | Sell |
1,661,248
-761,364
| -31% | -$48.4M | 0.48% | 61 |
|
|
2025
Q4 | $154M | Sell |
2,422,612
-360,318
| -13% | -$22.4M | 0.7% | 50 |
|
|
2025
Q3 | $153M | Sell |
2,782,930
-15,471
| -0.6% | -$637K | 0.74% | 39 |
|
|
2025
Q2 | $92.5M | Buy |
2,798,401
+342,664
| +14% | +$11.9M | 0.49% | 56 |
|
|
2025
Q1 | $98.7M | Buy |
2,455,737
+259,016
| +12% | +$11.9M | 0.6% | 47 |
|
|
2024
Q4 | $103M | Sell |
2,196,721
-141,126
| -6% | -$7.33M | 0.58% | 49 |
|
|
2024
Q3 | $123M | Sell |
2,337,847
-116,818
| -5% | -$6.51M | 0.59% | 38 |
|
|
2024
Q2 | $133M | Buy |
2,454,665
+849,089
| +53% | +$51.3M | 0.78% | 33 |
|
|
2024
Q1 | $113M | Buy |
1,605,576
+188,522
| +13% | +$14.6M | 0.59% | 41 |
|
|
2023
Q4 | $118M | Sell |
1,417,054
-1,237,391
| -47% | -$44.8M | 0.73% | 32 |
|
|
2023
Q3 | $78.2M | Hold |
2,654,445
| – | – | 0.58% | 50 |
|
|
2023
Q2 | $86.6M | Buy |
2,654,445
+42,753
| +2% | +$1.58M | 0.59% | 54 |
|
|
2023
Q1 | $91.9M | Sell |
2,611,692
-113,085
| -4% | -$4.61M | 0.67% | 45 |
|
|
2022
Q4 | $125M | Buy |
2,724,777
+53,129
| +2% | +$2.29M | 1% | 21 |
|
|
2022
Q3 | $129K | Sell |
2,671,648
-355,000
| -12% | -$17.1M | 0.82% | 20 |
|
|
2022
Q2 | $119K | Sell |
3,026,648
-154,652
| -5% | -$6.23M | 0.7% | 26 |
|
|
2022
Q1 | $117K | Sell |
3,181,300
-490,669
| -13% | -$17.4M | 0.54% | 36 |
|
|
2021
Q4 | $167K | Buy |
3,671,969
+657,087
| +22% | +$25.4M | 0.67% | 30 |
|
|
2021
Q3 | $108K | Buy |
3,014,882
+585,782
| +24% | +$17.2M | 0.47% | 45 |
|
|
2021
Q2 | $48.1K | Sell |
2,429,100
-242,784
| -9% | -$5.7M | 0.21% | 105 |
|
|
2021
Q1 | $62.1M | Sell |
2,671,884
-600,000
| -18% | -$12.8M | 0.39% | 76 |
|
|
2020
Q4 | $68M | Buy |
+3,271,884
| New | +$59.8M | 0.44% | 70 |
|
Other funds holding CYTK
VPM
VCM
ACA
